# OnCo record dr-reddys (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dr-reddys/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dr-reddys" ;
  schema:name "Dr. Reddy's Laboratories"@en ;
  schema:description "The Hyderabad generics maker that launched the world's first rituximab biosimilar in 2007 and now sells oncology generics and biosimilars in India, the US and Europe."@en ;
  schema:url <https://onco.cc/companies/dr-reddys/>, <https://www.drreddys.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Dr._Reddy's_Laboratories> ;
  owl:sameAs <http://www.wikidata.org/entity/Q908961> ;
  schema:citation <https://www.drreddys.com> ;
  schema:addressCountry "IN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/azacitidine/> ;
  onco:companies <https://onco.cc/companies/aurigene/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/> .